BR0012301A - Epithelial cell growth inhibitors - Google Patents

Epithelial cell growth inhibitors

Info

Publication number
BR0012301A
BR0012301A BR0012301-3A BR0012301A BR0012301A BR 0012301 A BR0012301 A BR 0012301A BR 0012301 A BR0012301 A BR 0012301A BR 0012301 A BR0012301 A BR 0012301A
Authority
BR
Brazil
Prior art keywords
epithelial cell
cell growth
growth inhibitors
epithelial
ecgi
Prior art date
Application number
BR0012301-3A
Other languages
Portuguese (pt)
Inventor
Raul R Ervin Jr
Original Assignee
Biotherapies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotherapies Inc filed Critical Biotherapies Inc
Publication of BR0012301A publication Critical patent/BR0012301A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: "INIBIDORES DE CRESCIMENTO DE CéLULAS EPITELIAIS". Os inibidores de crescimento de células epiteliais diferencialmente expressam em células epiteliais cancerosas e normais. As proteínas ECGI e sequência de ácido nucleico codificando as mesmas são utilizáveis no diagnóstico e tratamento de cânceres de células epiteliais, por exemplo próstata, ovariano, câncer do cólon e outros.Invention Patent: "EPITHELIAL CELL GROWTH INHIBITORS". Epithelial cell growth inhibitors differentially express on cancerous and normal epithelial cells. The ECGI proteins and nucleic acid sequence encoding them are usable in the diagnosis and treatment of epithelial cell cancers, for example prostate, ovarian, colon cancer and others.

BR0012301-3A 1999-06-18 2000-06-19 Epithelial cell growth inhibitors BR0012301A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13999599P 1999-06-18 1999-06-18
PCT/US2000/016900 WO2000078955A1 (en) 1999-06-18 2000-06-19 Epithelial cell growth inhibitors

Publications (1)

Publication Number Publication Date
BR0012301A true BR0012301A (en) 2002-03-26

Family

ID=22489251

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0012301-3A BR0012301A (en) 1999-06-18 2000-06-19 Epithelial cell growth inhibitors

Country Status (13)

Country Link
EP (1) EP1190054A1 (en)
JP (1) JP2003513615A (en)
KR (1) KR20020016837A (en)
CN (1) CN1399680A (en)
AU (1) AU783373B2 (en)
BR (1) BR0012301A (en)
CA (1) CA2375498A1 (en)
IL (1) IL147148A0 (en)
MX (1) MXPA01013242A (en)
NZ (1) NZ516545A (en)
PL (1) PL352997A1 (en)
WO (1) WO2000078955A1 (en)
ZA (1) ZA200200145B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500937B1 (en) 1996-10-03 2002-12-31 University Of Michigan Nucleotide sequence encoding a mammary cell growth inhibitor
US6342533B1 (en) 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
WO2001098496A1 (en) * 2000-06-19 2001-12-27 The University Of Michigan Mammastatin sequence variant c
CN102787092B (en) * 2011-05-17 2018-01-09 李晖 Culture medium, kit for cell culture, and cell culture method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031625A1 (en) * 1995-04-07 1996-10-10 Cytogen Corporation Polypeptides having a functional domain of interest and methods of identifying and using same
EP0929675A2 (en) * 1996-10-03 1999-07-21 Biotherapies, Inc. Nucleotide and protein sequence of mammastatin and methods of use
US6500937B1 (en) * 1996-10-03 2002-12-31 University Of Michigan Nucleotide sequence encoding a mammary cell growth inhibitor

Also Published As

Publication number Publication date
WO2000078955A1 (en) 2000-12-28
MXPA01013242A (en) 2002-11-04
CA2375498A1 (en) 2000-12-28
JP2003513615A (en) 2003-04-15
AU783373B2 (en) 2005-10-20
IL147148A0 (en) 2002-08-14
CN1399680A (en) 2003-02-26
NZ516545A (en) 2004-06-25
KR20020016837A (en) 2002-03-06
WO2000078955A9 (en) 2002-09-06
AU6052300A (en) 2001-01-09
ZA200200145B (en) 2003-04-30
PL352997A1 (en) 2003-09-22
EP1190054A1 (en) 2002-03-27

Similar Documents

Publication Publication Date Title
TR199701462T1 (en) DNA Sequence and the breast-specific breast cancer protein encoded with it.
BR0109062A (en) Aryl fructose-1,6-bisphosphatase inhibitors
BR0315666A (en) A34 and a33 type 3 dna, proteins, their antibodies and treatment methods using the same
WO2003004989A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
DK1112275T3 (en) Novel heteroaromatic inhibitors of fructose-1,6-bisphosphatase
DE60214134D1 (en) MODIFIED PSMA LIGANDS AND THEIR USE
MXPA02002384A (en) Fibroblast growth factor like polypeptides.
DE69837529D1 (en) PROTEIN MARKERS FOR LUNG CANCER AND ITS USE
WO2003050243A3 (en) Novel genes encoding colon cancer antigens
WO2002071928A3 (en) Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
ATE402188T1 (en) BINDING PROTEINS AS BIOSENSORS
WO2003000012A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
WO2002078598A3 (en) Peptides and antibodies to muc 1 proteins
DK1007537T3 (en) Receptor protein designated 2F1
DE60138715D1 (en) TNF-RECEPTOR-SIMILAR MOLECULES AND THEIR APPLICATIONS
WO2000055629A3 (en) Methods of diagnosing and treating breast cancer
AU2740100A (en) A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
WO2002031209A3 (en) Genes related to development of refractory prostate cancer
DK1082423T3 (en) Cyclin E2 genes and proteins
DE60044350D1 (en) PROSTATE SPECIFIC GEN PCGEM1 AND METHODS OF USE FOR THE RECOGNITION, TREATMENT AND PREVENTION OF PROSTATE CANCER
BR0012301A (en) Epithelial cell growth inhibitors
NZ516237A (en) Meth1 and meth2 polynucleotides and polypeptides
SE9500030D0 (en) Method of determining metastatic potential of tumor cells
WO2002081640A3 (en) Gene shinc-1 and diagnostic and therapeutic uses thereof
DE69733491D1 (en) Gene product overexpressed in cancer cells

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A, 5A, 6A, E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1929 DE 26/12/2007.